Compare CABA & TREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CABA | TREE |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 495.7M | 533.1M |
| IPO Year | 2019 | 2008 |
| Metric | CABA | TREE |
|---|---|---|
| Price | $3.25 | $27.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $14.50 | ★ $71.25 |
| AVG Volume (30 Days) | ★ 4.2M | 503.8K |
| Earning Date | 05-14-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.26 | ★ 443.31 |
| EPS | N/A | ★ 1.90 |
| Revenue | N/A | ★ $1,117,324,000.00 |
| Revenue This Year | N/A | $19.03 |
| Revenue Next Year | N/A | $7.07 |
| P/E Ratio | ★ N/A | $14.76 |
| Revenue Growth | N/A | ★ 24.12 |
| 52 Week Low | $1.44 | $27.51 |
| 52 Week High | $4.23 | $77.35 |
| Indicator | CABA | TREE |
|---|---|---|
| Relative Strength Index (RSI) | 58.51 | 26.31 |
| Support Level | $3.12 | N/A |
| Resistance Level | $3.34 | $39.74 |
| Average True Range (ATR) | 0.22 | 1.16 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 68.32 | 5.50 |
Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.